Key Takeaways
- The 9th Annual Corporate Compliance & Transparency in Life Sciences conference takes place on 17 to 18 November 2026 in Zurich, Switzerland, organised by Fleming.
- Priya Life Science readers get an exclusive 20 percent discount on delegate tickets with the promo code corporate20.
- The programme covers the EU AI Act, AI governance and human oversight, third-party and anti-corruption risk, GDPR and pharmacovigilance, and ethical HCP and patient engagement.
- Confirmed speakers include senior compliance leaders from Novartis, CSL, Roche, Bayer, Amgen, Novo Nordisk, Bristol Myers Squibb, Baxter, the WHO Foundation, Transparency International and The World Bank Group.
- Single delegate tickets start from 1,896 EUR; the corporate20 code brings that to roughly 1,517 EUR.
If your 2027 compliance planning has to answer for AI systems, tightening European enforcement and increasingly complex third-party ecosystems, this is the room to be in. The Corporate Compliance & Transparency in Life Sciences conference returns for its ninth edition under the theme "Navigating AI, Data, and Global Enforcement in a New Era of Integrity", bringing together more than 100 senior professionals from pharma, biotech, medtech, diagnostics and digital health.
Register here: Corporate Compliance & Transparency in Life Sciences 2026, official registration and use promo code corporate20 at checkout for 20 percent off delegate tickets.
Event at a Glance
| Event | 9th Annual Corporate Compliance & Transparency in Life Sciences |
| Dates | 17 to 18 November 2026 |
| Location | Zurich, Switzerland |
| Organiser | Fleming (fleming.events) |
| Theme | Navigating AI, Data, and Global Enforcement in a New Era of Integrity |
| Format | 20+ speakers, 15+ presentations and case studies, interactive roundtables, live polling, 6+ hours of networking |
| Discount code | corporate20 (20 percent off delegate tickets, exclusive for Priya Life Science readers) |
Ticket Prices and the 20 Percent Discount
Published delegate rates and what they look like once the corporate20 code is applied at checkout:
| Ticket | Standard price | With code corporate20 |
|---|---|---|
| 1 delegate | from 1,896 EUR | from about 1,517 EUR |
| 2 delegates | 2,596 EUR (reduced from 3,792 EUR) | about 2,077 EUR |
| 3 delegates | 2,996 EUR (reduced from 5,688 EUR) | about 2,397 EUR |
| Solution provider | from 3,099 EUR | Code applies to delegate tickets |
Prices are published by the organiser and may change. Discounted figures are indicative, based on a 20 percent reduction of the listed delegate rates; the final price is confirmed at checkout. Tickets are valid for industry professionals.
What Is on the Agenda
Day 1, 17 November 2026: AI governance, culture and third-party risk
- Opening keynote: "The 2030 Compliance Officer: From Gatekeeper to Strategic Futurist" by Brett Hudson, VP Ethics, Risk & Compliance at Novartis.
- Panel: the EU AI Act in life sciences, covering high-risk AI systems in diagnostics and drug development, mandatory AI literacy programmes and the intersection with MDR and IVDR obligations.
- Sessions on scaling compliance through champions in biotech, sustaining a culture of integrity, compliance as a competitive advantage in emerging markets, anti-corruption enforcement in Europe, the compliance challenges of personalised medicine, and human oversight of AI from policy to daily practice.
- Interactive roundtables on business enablement, fragmented third-party risk, practical AI governance, and patient trust in data use.
Day 2, 18 November 2026: patients, privacy and global enforcement
- Keynote: "Trust is the New Currency: Strengthening Integrity in Life Sciences" on patient engagement across the product lifecycle.
- Panels: the future of ethical interactions with HCPs and patients, and global anti-corruption enforcement priorities of the DOJ, SEC and European bodies.
- Presentations on distributor monitoring, the gene therapy compliance frontier, AI and automation in ABAC programmes, governing partners without becoming a regulator, and the tension between GDPR erasure rights and pharmacovigilance obligations.
Who You Will Meet
The current programme features senior compliance, ethics, privacy and governance leaders from Novartis, CSL, Novo Nordisk, the WHO Foundation, Bristol Myers Squibb, Bayer, Roche, Amgen, Baxter, Chiesi Farmaceutici, Alnylam Pharmaceuticals, Amarin, Arcera Lifesciences, Transparency International and The World Bank Group. Ireland is represented too: Caroline Kelly, Founder and CEO of Pharma Integrity, joins the speaker line-up.
Attendees typically include chief compliance officers, heads of ethics and integrity, privacy counsel, regulatory affairs leaders, quality and governance professionals, and advisers from law firms and consultancies working across pharma, biotech, medtech and digital health.
Why This Conference Matters for 2027 Planning
- Regulatory readiness: actionable strategies for the EU AI Act and EU Data Act, plus the practical impact of the updated EFPIA and ABPI Codes of Practice.
- Enforcement insight: direct perspectives from EU regulators, national authorities and trade associations on how frameworks are applied across Member States.
- Next-generation challenges: AI in promotional and operational settings, ethical boundaries in patient support programmes, and oversight of connected devices and real-world data partnerships.
- Community: a focused European forum where compliance leaders compare approaches through case studies and peer discussion rather than theory.
How to Register with the Discount
- Open the official registration page.
- Choose your delegate ticket.
- Enter the promo code corporate20 at checkout to apply the 20 percent reader discount.
Frequently Asked Questions
When and where does the conference take place?
On 17 and 18 November 2026 in Zurich, Switzerland. Day 1 runs from 08:30 registration to a 17:15 close with a networking reception; Day 2 closes at 15:30.
How do I get the 20 percent discount?
Enter the code corporate20 when registering through the official Fleming registration page. The code applies to delegate tickets and is shared with Priya Life Science readers through our media partnership with the event.
Who should attend?
Senior compliance, ethics, privacy, governance, legal and regulatory professionals across pharma, biotech, medtech, diagnostics, CDMOs and digital health, along with law firms and patient organisations working with the sector.
Is there a group rate?
Yes. The organiser publishes reduced multi-delegate bundles: two delegates for 2,596 EUR and three delegates for 2,996 EUR, before any promo code.
What topics dominate the 2026 edition?
AI governance under the EU AI Act, human oversight of AI, third-party and indirect-influence risk, anti-bribery and anti-corruption enforcement, data privacy in personalised medicine, and ethical engagement with healthcare professionals and patients.
For a deeper editorial analysis of why AI governance is becoming the defining compliance test for the sector, read our companion article: AI Governance Is Becoming the Next Major Compliance Test for Life Sciences.
